Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development

BACKGROUND: COPD is a pulmonary disorder often accompanied by cardiovascular disease (CVD), and current treatment of this comorbidity is suboptimal. Systemic inflammation in COPD triggered by smoke and microbial exposure is suggested to link COPD and CVD. Mesenchymal stromal cells (MSC) possess anti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Khedoe, P. Padmini S. J., de Kleijn, Stan, van Oeveren-Rietdijk, Annemarie M., Plomp, Jaap J., de Boer, Hetty C., van Pel, Melissa, Rensen, Patrick C. N., Berbée, Jimmy F. P., Hiemstra, Pieter S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5598950/
https://ncbi.nlm.nih.gov/pubmed/28910300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183741
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia